Kevin Kotler and 2 Others Buys $320K of Biodelivery Sciences International Inc (BDSI) — SEC Form 4, Nov 15, 2021

Open-Market Net Purchase · SEC Form 4
+$320,000

Equity position changed by +2.0%

Reporting Owners
Director
TXN 2021-11-12 · FILED 2021-11-15
Equity Position 5.06M sh 4,958,489 → 5,058,489
Equity Change +2.0% shares held after vs before
Filing Lag 1 business day within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Filing Date
2021-11-15
Report Date
2021-11-12
Accession No.
0001103021-21-000114
Accepted At
2021-11-15 07:56 UTC
Reporting Owners
Name Relationship
Kevin Kotler CIK 0001601692
Director
Broadfin Capital, LLC CIK 0001511901
Director
Broadfin Healthcare Master Fund Ltd CIK 0001511900
Director
Kevin Kotler at Biodelivery Sciences International Inc Full insider history
Bought (12 mo) —
Sold (12 mo) —
More from this insider at Biodelivery Sciences International Inc
2022-03-22 Gift/Other — View
2022-02-15 - — View
2022-01-31 Exercise — View
2021-11-22 Buy +$306,000 View
2021-11-09 Buy +$894,566 View
All filings by this insider at Biodelivery Sciences International Inc
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Common StockF1F2 2021-11-12 P - Purchase 100,000 A $3.20 +$320,000 5,058,489 Indirect
Footnotes (2)
F1
4,400,689 shares of Common Stock are held in the account of Broadfin Healthcare Master Fund, Ltd., a private investment fund managed by Broadfin Capital, LLC, and may be deemed to be beneficially owned by Kevin Kotler, managing member of Broadfin Capital, LLC. Broadfin Healthcare Master Fund, Ltd., Broadfin Capital, LLC, and Kevin Kotler affirmatively (i) disclaim beneficial ownership of the reportable securities, (ii) states that this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 ("Section 16") of the Securities Exchange Act of 1934, as amended (the "Act") or any other purpose, except to the extent of their pecuniary interest therein, and (iii) disclaim being a "group" for purposes of Section 16. Show more
F2
657,800 shares of Common Stock are held in the account of Broadfin Holdings, LLC., a private investment fund, and are deemed to be beneficially owned by Kevin Kotler, managing member of Broadfin Holdings, LLC. Show more
Other insiders at Biodelivery Sciences International Inc
All Biodelivery Sciences International Inc insider activity
GET /v1/forms/4/0001103021-21-000114 API docs
View Original SEC Filing